You are now leaving consilienthealth.ie

You are about to exit the Consilient Health website to visit an independent third party website which is not under the control of Consilient Health. Consilient Health makes no warranties or representations of any kind as to the accuracy, completeness, reliability or usefulness of any information contained in third party sites and shall have no liability for any loss or damage of any kind that may arise from your use of such content or information.

Inclusion of any third party link does not imply an endorsement or recommendation by Consilient Health Ltd.

Please click ok if you wish to continue to the third party website or click cancel if you wish to return to altavita.ie.

OK

Link to: Blissel
Vaginal atrophy How Blissel works Dosing Useful resources FAQs Back to main site

BlisselⓇ was created to release women from the symptoms of vaginal atrophy

BlisselⓇ is an ultra low dose estriol vaginal gel containing 50 micrograms per dose (1 gram) of estriol. 1,2

BlisselⓇ is indicated for treating the symptoms of vaginal atrophy due to oestrogen deficiency in postmenopausal women.1

BlisselⓇ turns back the clock on vaginal changes due to the menopause:

Reversal of the cellular changes that lead to vaginal atrophy2:

Significantly higher maturation value vs placebo (p0.001) after 12 weeks treatment.

Stops the pH changes that occur in vaginal atrophy2:

Significantly lower pH vs placebo (p0.001) after 12 weeks treatment.

Mucoadhesive Gel3

The BlisselⓇ formulation may assist the therapeutic effect whilst reducing leakage.

BlisselⓇ uses polycarbophilic components to form a mucoadhesive gel.3

This works synergistically with the estriol by providing a moisturising effect whilst increasing the retention and penetration of the hormonal component.3

Non-mucoadhesive products

Non-mucoadhesive products may have shorter vaginal contact times and produce leakage.3

Formulation

The formulation of BlisselⓇ may allow your patients to retain more of the active ingredient, whilst reducing mess and leakage.

  1. BlisselⓇ 50 micrograms/g vaginal gel. Summary of product characteristics. 2. Cano A, et al. Menopause. 2012;19(10):1130-9. 3. Lázaro-Carrasco de la Fuente J, et al. J Menopausal Med. 2022;28(2):60-69.

Summary of Product Characteristics can be found at www.medicines.ie

The information on this website is intended for Republic of Ireland residents only.
IE-CH-1362(1) Date of Preparation November 2024

© Consilient Health Ltd. All rights reserved.

Adverse Events / Product Complaints or for Pharmacovigilance or Medical enquiries please contact:
E: drugsafety@consilienthealth.com
T: (01) 205 7766
All other queries: (01) 205 7760

  • Careers
  • Transfer of Value
  • Privacy Policy
  • Cookies
  • Terms
  • Sitemap
Scroll to top

This site is intended for Healthcare Professionals registered in Ireland. By clicking to enter this site you are confirming that you are a Healthcare Professional registered in Ireland.

Continue Cancel